NICE backs Alimera’s three-year uveitis implantAn implant developed by Alimera Sciences has been recommended by NICE to treat an inflammatory eye disease that Share XNICE backs Alimera’s three-year uveitis implanthttps://pharmaphorum.com/news/nice-backs-alimeras-three-year-uveitis-implant/
Your Latest Ophthalmology News for SMi’s Ophthalmic Drugs 2018Ophthalmic Drugs Conference London Share XYour Latest Ophthalmology News for SMi’s Ophthalmic Drugs 2018https://pharmaphorum.com/partner-content/your-latest-ophthalmology-news-for-smis-ophthalmic-drugs-2018/